title: A rare HIV reverse transcriptase mutation, K65N, confers reduced susceptibility to tenofovir, lamivudine and didanosine.
authors.forename: Lisa L
authors.initials: LL
authors.lastname: Ross
authors.forename: Robin
authors.initials: R
authors.lastname: Dretler
authors.forename: Peter
authors.initials: P
authors.lastname: Gerondelis
authors.forename: Elizabeth G
authors.initials: EG
authors.lastname: Rouse
authors.forename: Michael L
authors.initials: ML
authors.lastname: Lim
authors.forename: Ernest R
authors.initials: ER
authors.lastname: Lanier
mesh_terms: D000328:Adult; D023241:Antiretroviral Therapy, Highly Active; D024882:Drug Resistance, Viral / Q000235:genetics; D015658:HIV Infections / Q000188:drug therapy*; D054303:HIV Reverse Transcriptase / Q000235:genetics*; D015497:HIV-1 / Q000201:enzymology*; D006801:Humans; D008297:Male; D009154:Mutation; D018894:Reverse Transcriptase Inhibitors / Q000627:therapeutic use*
chemical_list: D018894:Reverse Transcriptase Inhibitors; D054303:HIV Reverse Transcriptase